Stem cells and injectable hydrogels: Synergistic therapeutics in myocardial repair

Biotechnology Advances

Volumn 34, Issue 4, 2016, Pages 362-379

  Sepantafar, Mohammadmajid ^a,b   Maheronnaghsh, Reihan ^c   Mohammadi, Hossein ^d   Rajabi Zeleti, Sareh ^a   Annabi, Nasim ^e,f,g,h   Aghdami, Nasser ^a   Baharvand, Hossein ^a,i  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b SEMNAN UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d SCHOOL OF MATERIALS AND MINERAL RESOURCES ENGINEERING   (Malaysia)

^e Northeastern University   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^h HARVARD UNIVERSITY   (United States)

ⁱ UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

Infarction; Injectable hydrogel; Myocardial tissue engineering; Regeneration; Stem cell transplantation

Indexed keywords

CARDIOLOGY; CELL ENGINEERING; CELLS; CYTOLOGY; DISEASES; REPAIR; STEM CELLS; TISSUE; TISSUE ENGINEERING; TISSUE REGENERATION;

INFARCTION; INJECTABLE HYDROGELS; MYOCARDIAL TISSUE ENGINEERING; REGENERATION; STEM CELL TRANSPLANTATION;

HYDROGELS;

BIOENGINEERING; CARDIOLOGY; CARDIOVASCULAR DISEASE; CELLS AND CELL COMPONENTS; DISEASE TREATMENT; GEL;

ADMINISTRATION AND DOSAGE; ANIMAL; CARDIAC MUSCLE; CYTOLOGY; HEART; HEART INFARCTION; HUMAN; HYDROGEL; METABOLISM; MOUSE; PHYSIOLOGY; REGENERATION; STEM CELL TRANSPLANTATION; THERAPEUTIC USE; TISSUE ENGINEERING;

ANIMALS; HEART; HUMANS; HYDROGELS; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; REGENERATION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84977962768     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2016.03.003     Document Type: Review

References (206)

1. Aguado B.A., Mulyasasmita W., Su J., Lampe K.J., Heilshorn S.C. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng. A 2011, 18:806-815.
2. Alsberg E., Anderson K., Albeiruti A., Franceschi R., Mooney D. Cell-interactive alginate hydrogels for bone tissue engineering. J. Dent. Res. 2001, 80:2025-2029.
3. Annabi N., Mithieux S.M., Zorlutuna P., Camci-Unal G., Weiss A.S., Khademhosseini A. Engineered cell-laden human protein-based elastomer. Biomaterials 2013, 34:5496-5505.
4. Annabi N., Tamayol A., Uquillas J.A., Akbari M., Bertassoni L.E., Cha C., et al. 25th anniversary article: rational design and applications of hydrogels in regenerative medicine. Adv. Mater. 2014, 26:85-124.
5. Annabi N., Tsang K., Mithieux S.M., Nikkhah M., Ameri A., Khademhosseini A., et al. Highly elastic micropatterned hydrogel for engineering functional cardiac tissue. Adv. Funct. Mater. 2013, 23:4950-4959.
6. Atluri P., Miller J.S., Emery R.J., Hung G., Trubelja A., Cohen J.E., et al. Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function. J. Thorac. Cardiovasc. Surg. 2014, 148:1090-1098.
7. Babavalian H., Sepantafar M.M., Mohammadi H., Shakeri F., Khodi S. Growth factor containing hydrogels for tissue engineering applications. J. Appl. Biotechnol. Rep. 2014, 1:89-96.
8. Badylak S.F. The extracellular matrix as a biologic scaffold material. Biomaterials 2007, 28:3587-3593.
9. Badylak S.F., Freytes D.O., Gilbert T.W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 2009, 5:1-13.
10. Baig M.K., Mahon N., McKenna W.J., Caforio A.L., Bonow R.O., Francis G.S., et al. The pathophysiology of advanced heart failure. Am. Heart J. 1998, 135:S216-S230.
11. Ban K., Park H.-J., Kim S., Andukuri A., Cho K.-W., Hwang J.W., et al. Cell therapy with embryonic stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair. ACS Nano 2014, 8:10815-10825.
12. Bao W., Hu E., Tao L., Boyce R., Mirabile R., Thudium D.T., et al. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovasc. Res. 2004, 61:548-558.
13. Barczyk M., Carracedo S., Gullberg D. Integrins. Cell Tissue Res. 2010, 339:269-280.
14. Barocas V.H., Moon A.G., Tranquillo R.T. The fibroblast-populated collagen microsphere assay of cell traction force-part 2: measurement of the cell traction parameter. J. Biomech. Eng. 1995, 117:161.
15. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
16. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabé-Heider F., Walsh S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
17. Berthiaume F., Maguire T.J., Yarmush M.L. Tissue engineering and regenerative medicine: history, progress, and challenges. Annu. Rev. Chem. Biomol. Eng. 2011, 2:403-430.
18. Blatchley M.R., Gerecht S. Acellular implantable and injectable hydrogels for vascular regeneration. Biomed. Mater. 2015, 10:034001.
19. Blocki A., Beyer S., Dewavrin J.-Y., Goralczyk A., Wang Y., Peh P., et al. Microcapsules engineered to support mesenchymal stem cell (MSC) survival and proliferation enable long-term retention of MSCs in infarcted myocardium. Biomaterials 2015, 53:12-24.
20. Bökel C., Brown N.H. Integrins in development: moving on, responding to, and sticking to the extracellular matrix. Dev. Cell 2002, 3:311-321.
21. Bonaros N., Rauf R., Schachner T., Laufer G., Kocher A. Enhanced cell therapy for ischemic heart disease. Transplantation 2008, 86:1151-1160.
22. Boopathy A.V., Che P.L., Somasuntharam I., Fiore V.F., Cabigas E.B., Ban K., et al. The modulation of cardiac progenitor cell function by hydrogel-dependent Notch1 activation. Biomaterials 2014, 35:8103-8112.
23. Bosman F.T., Stamenkovic I. Functional structure and composition of the extracellular matrix. J. Pathol. 2003, 200:423-428.
24. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 2006, 7:678-689.
25. Buckberg G.D. Basic science review: the helix and the heart. J. Thorac. Cardiovasc. Surg. 2002, 124:863-883.
26. Buikema J.W., Van Der Meer P., Sluijter J.P., Domian I.J. Concise review: engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technology. Stem cells (Dayton, Ohio) 2013, 31:2587-2598.
27. Burchfield J.S., Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair 2008, 1:4.
28. Burdick J.A., Dorsey S.M. Biomaterials for treating myocardial infarctions. Front. Of. 2015, 82.
29. Camci-Unal G., Cuttica D., Annabi N., Demarchi D., Khademhosseini A. Synthesis and characterization of hybrid hyaluronic acid-gelatin hydrogels. Biomacromolecules 2013, 14:1085-1092.
30. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 2007, 100:263-272.
31. Caulfield J.B., Borg T.K. The collagen network of the heart. Lab. Investig. 1979, 40:364-372.
32. Cha C., Shin S.R., Gao X., Annabi N., Dokmeci M.R., Tang X.S., et al. Controlling mechanical properties of cell-laden hydrogels by covalent incorporation of graphene oxide. Small (Weinheim an der Bergstrasse, Germany) 2014, 10:514-523.
33. Chachques J.C., Trainini J.C., Lago N., Masoli O.H., Barisani J.L., Cortes-Morichetti M., et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant. 2007, 16:927-934.
34. Chen S.-l., Fang W.-w., Ye F., Liu Y.-H., Qian J., Shan S.-j., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 2004, 94:92-95.
35. Chen J., Guo R., Zhou Q., Wang T. Injection of composite with bone marrow-derived mesenchymal stem cells and a novel synthetic hydrogel after myocardial infarction: a protective role in left ventricle function. Kaohsiung J. Med. Sci. 2014, 30:173-180.
36. Cheng X.W., Obata K., Kuzuya M., Izawa H., Nakamura K., Asai E., et al. Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure. Hypertension 2006, 48:979-987.
37. Chi N.-H., Yang M.-C., Chung T.-W., Chen J.-Y., Chou N.-K., Wang S.-S. Cardiac repair achieved by bone marrow mesenchymal stem cells/silk fibroin/hyaluronic acid patches in a rat of myocardial infarction model. Biomaterials 2012, 33:5541-5551.
38. Chimenti I., Smith R.R., Li T.-s., Gerstenblith G., Messina E., Giacomello A., et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res. 2010, 106:971-980.
39. Christman K.L., Fok H.H., Sievers R.E., Fang Q., Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004, 10:403-409.
40. Corda S., Samuel J.-L., Rappaport L. Extracellular matrix and growth factors during heart growth. Heart Fail. Rev. 2000, 5:119-130.
41. Dai W., Wold L.E., Dow J.S., Kloner R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J. Am. Coll. Cardiol. 2005, 46:714-719.
42. Davis M.E., Hsieh P.C., Grodzinsky A.J., Lee R.T. Custom design of the cardiac microenvironment with biomaterials. Circ. Res. 2005, 97:8-15.
43. Davis M.E., Motion J.M., Narmoneva D.A., Takahashi T., Hakuno D., Kamm R.D., et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005, 111:442-450.
44. Davis M.E., Motion J.P., Narmoneva D.A., Takahashi T., Hakuno D., Kamm R.D., et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005, 111:442-450.
45. Dhoot N.O., Tobias C.A., Fischer I., Wheatley M.A. Peptide-modified alginate surfaces as a growth permissive substrate for neurite outgrowth. J. Biomed. Mater. Res. Part A 2004, 71:191-200.
46. Dobner S., Bezuidenhout D., Govender P., Zilla P., Davies N. A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling. J. Card. Fail. 2009, 15:629-636.
47. Dorsey S.M., Haris M., Singh A., Witschey W.R., Rodell C.B., Kogan F., et al. Visualization of injectable hydrogels using chemical exchange saturation transfer MRI. ACS Biomat. Sci. Eng. 2015, 1:227-237.
48. Duan Y., Liu Z., O'Neill J., Wan L.Q., Freytes D.O., Vunjak-Novakovic G. Hybrid gel composed of native heart matrix and collagen induces cardiac differentiation of human embryonic stem cells without supplemental growth factors. J. Cardiovasc. Transl. Res. 2011, 4:605-615.
49. Eghbali M., Blumenfeld O., Seifter S., Buttrick P., Leinwand L., Robinson T., et al. Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization. J. Mol. Cell. Cardiol. 1989, 21:103-113.
50. Engler A.J., Griffin M.A., Sen S., Bönnemann C.G., Sweeney H.L., Discher D.E. Myotubes differentiate optimally on substrates with tissue-like stiffness pathological implications for soft or stiff microenvironments. J. Cell Biol. 2004, 166:877-887.
51. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
52. Eriksson A., Cao R., Roy J., Tritsaris K., Wahlestedt C., Dissing S., et al. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation 2003, 107:1532-1538.
53. Eschenhagen T., Didié M., Heubach J., Ravens U., Zimmermann W.-H. Cardiac tissue engineering. Transpl. Immunol. 2002, 9:315-321.
54. Fischer-Rasokat U., Assmus B., Seeger F.H., Honold J., Leistner D., Fichtlscherer S., et al. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ. Heart Fail. 2009, 2:417-423.
55. Fisher S.A., Brunskill S.J., Doree C., Mathur A., Taggart D.P., Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Libr. 2014, 4.
56. Fomovsky G.M., Thomopoulos S., Holmes J.W. Contribution of extracellular matrix to the mechanical properties of the heart. J. Mol. Cell. Cardiol. 2010, 48:490-496.
57. Freytes D., Godier-Furnemont A., Duan Y., O'Neill J., Vunjack-Novakovic G. Biomaterial scaffolds for cardiac regeneration and repair derived from native heart matrix. Card. Regen. Repair Biomater. Tissue Eng. 2014, 2:201.
58. Fujimoto K.L., Ma Z., Nelson D.M., Hashizume R., Guan J., Tobita K., et al. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 2009, 30:4357-4368.
59. Ganji F., Abdekhodaie M., SA AR Gelation time and degradation rate of chitosan-based injectable hydrogel. J. Sol-Gel Sci. Technol. 2007, 42:47-53.
60. Garbern J.C., Lee R.T. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 2013, 12:689-698.
61. Garbern J.C., Minami E., Stayton P.S., Murry C.E. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials 2011, 32:2407-2416.
62. Gerecht-Nir S., Radisic M., Park H., Cannizzaro C., Boublik J., Langer R., et al. Biophysical regulation during cardiac development and application to tissue engineering. Int. J. Dev. Biol. 2006, 50:233.
63. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008, 103:1204-1219.
64. Goumans M.-J., De Boer T.P., Smits A.M., van Laake L.W., van Vliet P., Metz C.H., et al. TGF-β1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res. 2008, 1:138-149.
65. Guo H.-d., G-h Cui, Wang H.-j., Tan Y.-z. Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. 2010, 399:42-48.
66. Guo H.-d., G-h Cui, Yang J.-j., Wang C., Zhu J., Zhang L.-s., et al. Sustained delivery of VEGF from designer self-assembling peptides improves cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. 2012, 424:105-111.
67. Guo H.-D., Wang H.-J., Tan Y.-Z., Wu J.-H. Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. Tissue Eng. A 2010, 17:45-58.
68. Guvendiren M., Lu H.D., Burdick J.A. Shear-thinning hydrogels for biomedical applications. Soft Matter 2012, 8:260-272.
69. Han T., Nwe N., Furuike T., Tokura S., Tamura H. Methods of N-acetylated chitosan scaffolds and its in-vitro biodegradation by lysozyme. J. Biomed. Sci. Eng. 2012, 5:9.
70. Hao X., Silva E.A., Månsson-Broberg A., Grinnemo K.-H., Siddiqui A.J., Dellgren G., et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc. Res. 2007, 75:178-185.
71. Heusch G., Schulz R. The relation of contractile function to myocardial perfusion. Herz 1999, 24:509-514.
72. Hoffman A.S. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 2012, 64:18-23.
73. Hou D., Youssef E.A.-S., Brinton T.J., Zhang P., Rogers P., Price E.T., et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery implications for current clinical trials. Circulation 2005, 112:I-150-I-156.
74. Hsieh P.C., Davis M.E., Gannon J., MacGillivray C., Lee R.T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J. Clin. Investig. 2006, 116:237-248.
75. Hui E.E., Bhatia S.N. Micromechanical control of cell-cell interactions. Proc. Natl. Acad. Sci. 2007, 104:5722-5726.
76. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
77. Jeong B., Kim S.W., Bae Y.H. Thermosensitive sol-gel reversible hydrogels. Adv. Drug Deliv. Rev. 2002, 54:37-51.
78. Jiang X.J., Wang T., Li X.Y., Wu D.Q., Zheng Z.B., Zhang J.F., et al. Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction. J. Biomed. Mater. Res. Part A 2009, 90:472-477.
79. Joshi J.R., Kothapalli C. Nanofibers based tissue engineering and drug delivery approaches for myocardial regeneration. Curr. Pharm. Des. 2015, 21:2006-2020.
80. Kajstura J., Rota M., Whang B., Cascapera S., Hosoda T., Bearzi C., et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res. 2005, 96:127-137.
81. Kennedy J. Clinical anatomy series: cardiac anatomy. Scottish Univ. Med. J. 2012, 1:76-80.
82. Kim S., Healy K.E. Synthesis and characterization of injectable poly (N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links. Biomacromolecules 2003, 4:1214-1223.
83. Kofidis T., de Bruin J.L., Hoyt G., Lebl D.R., Tanaka M., Yamane T., et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J. Thorac. Cardiovasc. Surg. 2004, 128:571-578.
84. Kofidis T., Lebl D.R., Martinez E.C., Hoyt G., Tanaka M., Robbins R.C. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 2005, 112:I-173-I-177.
85. Komeri R., Thankam F.G., Muthu J. Influence of matrix and bulk behaviour of an injectable hydrogel on the survival of encapsulated cardiac cells. RSC Adv. 2015, 5:31439-31449.
86. Krause K., Jaquet K., Schneider C., Haupt S., Lioznov M., Otte K., et al. Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study. Heart 2009, 95:1145-1152.
87. Krenning G., Zeisberg E.M., Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 2010, 225:631-637.
88. Krupnick A.S., Kreisel D., Engels F.H., Szeto W.Y., Plappert T., Popma S.H., et al. A novel small animal model of left ventricular tissue engineering. J. Heart Lung transplant. 2002, 21:233-243.
89. Labovsky V., Hofer E.L., Feldman L., Fernandez Vallone V., Garcia Rivello H., Bayes-Genis A., et al. Cardiomyogenic differentiation of human bone marrow mesenchymal cells: role of cardiac extract from neonatal rat cardiomyocytes. Differ. Res. Biol. Divers. 2010, 79:93-101.
90. Landa N., Miller L., Feinberg M.S., Holbova R., Shachar M., Freeman I., et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008, 117:1388-1396.
91. Landau C., Jacobs A.K., Haudenschild C.C. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am. Heart J. 1995, 129:924-931.
92. Lanza R., Langer R., Vacanti J.P. Principles of Tissue Engineering 2011, Academic Press.
93. Lee J.S., Hong J.M., Moon G.J., Lee P.H., Ahn Y.H., Bang O.Y. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem cells (Dayton, Ohio) 2010, 28:1099-1106.
94. Lee K.Y., Kong H.J., Mooney D.J. Quantifying interactions between cell receptors and adhesion ligand-modified polymers in solution. Macromol. Biosci. 2008, 8:140-145.
95. LeGrice I.J., Smaill B., Chai L., Edgar S., Gavin J., Hunter P.J. Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog. Am. J. Physiol. Heart Circ. Physiol. 1995, 269:H571-H582.
96. Leor J., Amsalem Y., Cohen S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Ther. 2005, 105:151-163.
97. Leor J., Tuvia S., Guetta V., Manczur F., Castel D., Willenz U., et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J. Am. Coll. Cardiol. 2009, 54:1014-1023.
98. Leri A., Kajstura J., Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol. Rev. 2005, 85:1373-1416.
99. Li Z., Guan J. Hydrogels for cardiac tissue engineering. Polymer 2011, 3:740-761.
100. Li R.-K., Weisel R.D. Cardiac Regeneration and Repair: Biomaterials and Tissue Engineering 2014, Elsevier.
101. Li Y., Rodrigues J., Tomas H. Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. Chem. Soc. Rev. 2012, 41:2193-2221.
102. Lin Y.-D., Yeh M.-L., Yang Y.-J., Tsai D.-C., Chu T.-Y., Shih Y.-Y., et al. Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation 2010, 122:S132-S141.
103. Lisi A., Briganti E., Ledda M., Losi P., Grimaldi S., Marchese R., et al. A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells. PLoS ONE 2012, 7.
104. Liu Z., Wang H., Wang Y., Lin Q., Yao A., Cao F., et al. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials 2012, 33:3093-3106.
105. Lu H.D., Charati M.B., Kim I.L., Burdick J.A. Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanism. Biomaterials 2012, 33:2145-2153.
106. Lu W.-N., Lü S.-H., Wang H.-B., Li D.-X., Duan C.-M., Liu Z.-Q., et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng. A 2008, 15:1437-1447.
107. Lutolf M., Hubbell J. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 2005, 23:47-55.
108. Martens T.P., Godier A.F., Parks J.J., Wan L.Q., Koeckert M.S., Eng G.M., et al. Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant. 2009, 18:297.
109. Martin I., Wendt D., Heberer M. The role of bioreactors in tissue engineering. TRENDS Biotechnol. 2004, 22:80-86.
110. Mather B.D., Viswanathan K., Miller K.M., Long T.E. Michael addition reactions in macromolecular design for emerging technologies. Prog. Polym. Sci. 2006, 31:487-531.
111. McDevitt T.C., Woodhouse K.A., Hauschka S.D., Murry C.E., Stayton P.S. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J. Biomed. Mater. Res. Part A 2003, 66:586-595.
112. Meloty-Kapella L., Shergill B., Kuon J., Botvinick E., Weinmaster G. Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin. Dev. Cell 2012, 22:1299-1312.
113. Mukherjee R., Zavadzkas J.A., Saunders S.M., McLean J.E., Jeffords L.B., Beck C., et al. Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs. Ann. Thorac. Surg. 2008, 86:1268-1276.
114. Murry C.E., Whitney M.L., Reinecke H. Muscle cell grafting for the treatment and prevention of heart failure. J. Card. Fail. 2002, 8:S532-S541.
115. Nakanishi C., Yamagishi M., Yamahara K., Hagino I., Mori H., Sawa Y., et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2008, 374:11-16.
116. Narumiya S. The small GTPase Rho: cellular functions and signal transduction. J. Biochem. 1996, 120:215-228.
117. Nelson T.J., Martinez-Fernandez A., Yamada S., Perez-Terzic C., Ikeda Y., Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009, 120:408-416.
118. Nguyen Q.V., Park J.H., Lee D.S. Injectable polymeric hydrogels for the delivery of therapeutic agents: a review. Eur. Polym. J. 2015, 72:602-619.
119. Okada M., Payne T.R., Oshima H., Momoi N., Tobita K., Huard J. Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials 2010, 31:7678-7683.
120. Omens J.H. Stress and strain as regulators of myocardial growth. Prog. Biophys. Mol. Biol. 1998, 69:559-572.
121. Pahnke A., Montgomery M., Radisic M. Spatial and electrical factors regulating cardiac regeneration and assembly. Biomater. Card. Regen. Springer 2015, 71-92.
122. Park H., Radisic M., Lim J.O., Chang B.H., Vunjak-Novakovic G. A novel composite scaffold for cardiac tissue engineering. In Vitro Cell. Dev. Biol. Anim. 2005, 41:188-196.
123. Pascual-Gil S., Garbayo E., Díaz-Herráez P., Prosper F., Blanco-Prieto M.J. Heart regeneration after myocardial infarction using synthetic biomaterials. J. Control. Release 2015, 203:23-38.
124. Passier R., van Laake L.W., Mummery C.L. Stem-cell-based therapy and lessons from the heart. Nature 2008, 453:322-329.
125. Pezzato E., Donà M., Sartor L., Dell'Aica I., Benelli R., Albini A., et al. Proteinase-3 directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by (-) epigallocatechin-3-gallate. J. Leukoc. Biol. 2003, 74:88-94.
126. Pierschbacher M.D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 30-3.
127. Potta T., Chun C., Song S.-C. Chemically crosslinkable thermosensitive polyphosphazene gels as injectable materials for biomedical applications. Biomaterials 2009, 30:6178-6192.
128. Potta T., Chun C., Song S.-C. Injectable, dual cross-linkable polyphosphazene blend hydrogels. Biomaterials 2010, 31:8107-8120.
129. Radhakrishnan J., Krishnan U.M., Sethuraman S. Hydrogel based injectable scaffolds for cardiac tissue regeneration. Biotechnol. Adv. 2014, 32:449-461.
130. Radisic M., Yang L., Boublik J., Cohen R.J., Langer R., Freed L.E., et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H507-H516.
131. Rajabi-Zeleti S., Jalili-Firoozinezhad S., Azarnia M., Khayyatan F., Vahdat S., Nikeghbalian S., et al. The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds. Biomaterials 2014, 35:970-982.
132. Rask F., Dallabrida S.M., Ismail N.S., Amoozgar Z., Yeo Y., Rupnick M.A., et al. Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells. J. Biomed. Mater. Res. Part A 2010, 95:105-117.
133. Ravichandran R., Venugopal J.R., Sundarrajan S., Mukherjee S., Ramakrishna S. Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease. Int. J. Nanomedicine 2012, 7:5969.
134. Ravichandran R., Venugopal J.R., Sundarrajan S., Mukherjee S., Sridhar R., Ramakrishna S. Minimally invasive injectable short nanofibers of poly (glycerol sebacate) for cardiac tissue engineering. Nanotechnology 2012, 23:385102.
135. Ravichandran R., Venugopal J.R., Sundarrajan S., Mukherjee S., Ramakrishna S. Poly (glycerol sebacate)/gelatin core/shell fibrous structure for regeneration of myocardial infarction. Tissue Eng. A 2011, 17:1363-1373.
136. Ravichandran R., Venugopal J.R., Sundarrajan S., Mukherjee S., Sridhar R., Ramakrishna S. Expression of cardiac proteins in neonatal cardiomyocytes on PGS/fibrinogen core/shell substrate for Cardiac tissue engineering. Int. J. Cardiol. 2013, 167:1461-1468.
137. Reis L.A., Chiu L.L., Liang Y., Hyunh K., Momen A., Radisic M. A peptide-modified chitosan-collagen hydrogel for cardiac cell culture and delivery. Acta Biomater. 2012, 8:1022-1036.
138. Rimmer S. Biomedical Hydrogels: Biochemistry, Manufacture and Medical Applications 2011, Elsevier.
139. Rizzi S.C., Ehrbar M., Halstenberg S., Raeber G.P., Schmoekel H.G., Hagenmüller H., et al. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules 2006, 7:3019-3029.
140. Robb S.A., Lee B.H., McLemore R., Vernon B.L. Simultaneously physically and chemically gelling polymer system utilizing a poly (NIPAAm-co-cysteamine)-based copolymer. Biomacromolecules 2007, 8:2294-2300.
141. Robey T.E., Saiget M.K., Reinecke H., Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 2008, 45:567-581.
142. Robinson T.F., Geraci M.A., Sonnenblick E.H., Factor S.M. Coiled perimysial fibers of papillary muscle in rat heart: morphology, distribution, and changes in configuration. Circ. Res. 1988, 63:577-592.
143. Rowley J.A., Mooney D.J. Alginate type and RGD density control myoblast phenotype. J. Biomed. Mater. Res. 2002, 60:217-223.
144. Ruvinov E., Leor J., Cohen S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 2011, 32:565-578.
145. Ryu J.H., Kim I.-K., Cho S.-W., Cho M.-C., Hwang K.-K., Piao H., et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 2005, 26:319-326.
146. Sarig U., Machluf M. Engineering cell platforms for myocardial regeneration. Expert. Opin. Biol. Ther. 2011, 11:1055-1077.
147. Sato S., Ashraf M., Millard R., Fujiwara H., Schwartz A. Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. J. Mol. Cell. Cardiol. 1983, 15:261-275.
148. Schneider V.A., Mercola M. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev. 2001, 15:304-315.
149. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
150. Segers V.F., Tokunou T., Higgins L.J., MacGillivray C., Gannon J., Lee R.T. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007, 116:1683-1692.
151. Seidlits S.K., Khaing Z.Z., Petersen R.R., Nickels J.D., Vanscoy J.E., Shear J.B., et al. The effects of hyaluronic acid hydrogels with tunable mechanical properties on neural progenitor cell differentiation. Biomaterials 2010, 31:3930-3940.
152. Seif-Naraghi S.B., Horn D., Schup-Magoffin P.J., Christman K.L. Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor. Acta Biomater. 2012, 8:3695-3703.
153. Seliktar D. Extracellular stimulation in tissue engineering. Ann. N. Y. Acad. Sci. 2005, 1047:386-394.
154. Semler E.J., Ranucci C.S., Moghe P.V. Mechanochemical manipulation of hepatocyte aggregation can selectively induce or repress liver-specific function. Biotechnol. Bioeng. 2000, 69:359-369.
155. Shapira-Schweitzer K., Seliktar D. Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater. 2007, 3:33-41.
156. 2+ flux, PKC, and CamKII in vertebrate embryos. J. Cell Biol. 2003, 161:769-777.
157. Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J. Cardiovasc. Pharmacol. 2002, 39:319-327.
158. Shin M., Ishii O., Sueda T., Vacanti J. Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials 2004, 25:3717-3723.
159. Shin S.R., Jung S.M., Zalabany M., Kim K., Zorlutuna P., Kim Sb, et al. Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano 2013, 7:2369-2380.
160. Shu Y., Hao T., Yao F., Qian Y., Wang Y., Yang B., et al. RoY peptide-modified chitosan-based hydrogel to improve angiogenesis and cardiac repair under hypoxia. ACS Appl. Mater. Interfaces 2015, 7:6505-6517.
161. Singelyn J.M., Christman K.L. Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J. Cardiovasc. Transl. Res. 2010, 3:478-486.
162. Singelyn J.M., Christman K.L. Modulation of material properties of a decellularized myocardial matrix scaffold. Macromol. Biosci. 2011, 11:731-738.
163. Singelyn J.M., DeQuach J.A., Seif-Naraghi S.B., Littlefield R.B., Schup-Magoffin P.J., Christman K.L. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials 2009, 30:5409-5416.
164. Spinale F.G., Coker M.L., Heung L.J., Bond B.R., Gunasinghe H.R., Etoh T., et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000, 102:1944-1949.
165. Stankus J.J., Guan J., Wagner W.R. Fabrication of biodegradable elastomeric scaffolds with sub-micron morphologies. J. Biomed. Mater. Res. Part A 2004, 70:603-614.
166. Starr R., Willson T.A., Viney E.M., Murray L., Rayner J.R., Jenkins B.J., et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997, 387:917-921.
167. Stevens M.M., George J.H. Exploring and engineering the cell surface interface. Science 2005, 310:1135-1138.
168. Stokke B.T., Draget K.I., Smidsrød O., Yuguchi Y., Urakawa H., Kajiwara K. Small-angle X-ray scattering and rheological characterization of alginate gels. 1. Ca-alginate gels. Macromolecules 2000, 33:1853-1863.
169. Suleiman M.-S., Singh R., Stewart C. Apoptosis and the cardiac action of insulin-like growth factor I. Pharmacol. Ther. 2007, 114:278-294.
170. Suzuki Y.J. Cell signaling pathways for the regulation of GATA4 transcription factor: implications for cell growth and apoptosis. Cell. Signal. 2011, 23:1094-1099.
171. Tan H., Marra K.G. Injectable, biodegradable hydrogels for tissue engineering applications. Materials 2010, 3:1746-1767.
172. Teng C.J., Luo J., Chiu R.C., Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J. Thorac. Cardiovasc. Surg. 2006, 132:628-632.
173. Toeg H.D., Tiwari-Pandey R., Seymour R., Ahmadi A., Crowe S., Vulesevic B., et al. Injectable small intestine submucosal extracellular matrix in an acute myocardial infarction model. Ann. Thorac. Surg. 2013, 96:1686-1694.
174. Urech L., Bittermann A.G., Hubbell J.A., Hall H. Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. Biomaterials 2005, 26:1369-1379.
175. Wagner M., Siddiqui M.A. Signal transduction in early heart development (I): cardiogenic induction and heart tube formation. Exp. Biol. Med. (Maywood, NJ) 2007, 232:852-865.
176. Wang J.A., He A., Hu X., Jiang Y., Sun Y., Jiang J., et al. Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells. Int. J. Cardiol. 2009, 133:410-412.
177. Wang T., Jiang X.-J., Lin T., Ren S., Li X.-Y., Zhang X.-Z., et al. The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel. Biomaterials 2009, 30:4161-4167.
178. Wang T., Jiang X.-J., Tang Q.-Z., Li X.-Y., Lin T., Wu D.-Q., et al. Bone marrow stem cells implantation with α-cyclodextrin/MPEG-PCL-MPEG hydrogel improves cardiac function after myocardial infarction. Acta Biomater. 2009, 5:2939-2944.
179. Wang Y., Ahmad N., Wani M.A., Ashraf M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J. Mol. Cell. Cardiol. 2004, 37:1041-1052.
180. Wang H., Liu Z., Li D., Guo X., Kasper F.K., Duan C., et al. Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodelling and function of myocardial infarction. J. Cell. Mol. Med. 2012, 16:1310-1320.
181. Wang H., Shi J., Wang Y., Yin Y., Wang L., Liu J., et al. Promotion of cardiac differentiation of brown adipose derived stem cells by chitosan hydrogel for repair after myocardial infarction. Biomaterials 2014, 35:3986-3998.
182. Wang H., Tibbitt M.W., Langer S.J., Leinwand L.A., Anseth K.S. Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway. Proc. Natl. Acad. Sci. 2013, 110:19336-19341.
183. Wang T., Wu D.Q., Jiang X.J., Zhang X.Z., Li X.Y., Zhang J.F., et al. Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling. Eur. J. Heart Fail. 2009, 11:14-19.
184. Wang H., Zhou J., Liu Z., Wang C. Injectable cardiac tissue engineering for the treatment of myocardial infarction. J. Cell. Mol. Med. 2010, 14:1044-1055.
185. Williams C., Budina E., Stoppel W.L., Sullivan K.E., Emani S., Emani S.M., et al. Cardiac extracellular matrix-fibrin hybrid scaffolds with tunable properties for cardiovascular tissue engineering. Acta Biomater. 2015, 14:84-95.
186. Wollert K.C., Drexler H. Clinical applications of stem cells for the heart. Circ. Res. 2005, 96:151-163.
187. Wollert K.C., Meyer G.P., Lotz J., Lichtenberg S.R., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
188. Wu D.-Q., Qiu F., Wang T., Jiang X.-J., Zhang X.-Z., Zhuo R.-X. Toward the development of partially biodegradable and injectable thermoresponsive hydrogels for potential biomedical applications. ACS Appl. Mater. Interfaces 2008, 1:319-327.
189. Xi J., Khalil M., Shishechian N., Hannes T., Pfannkuche K., Liang H., et al. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. FASEB J. 2010, 24:2739-2751.
190. Xu G., Wang X., Deng C., Teng X., Suuronen E.J., Shen Z., et al. Injectable biodegradable hybrid hydrogels based on thiolated collagen and oligo(acryloyl carbonate)-poly(ethylene glycol)-oligo(acryloyl carbonate) copolymer for functional cardiac regeneration. Acta Biomater. 2015, 15:55-64.
191. Yamamoto T., Suto N., Okubo T., Mikuniya A., Hanada H., Yagihashi S., et al. Intramyocardial delivery of basic fibroblast growth factor-impregnated gelatin hydrogel microspheres enhances collateral circulation to infarcted canine myocardium. Jpn. Circ. J. 2001, 65:439-444.
192. Yanagisawa-Miwa A., Uchida Y., Nakamura F., Tomaru T., Kido H., Kamijo T., et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992, 257:1401-1403.
193. Yang D., Wang W., Li L., Peng Y., Chen P., Huang H., et al. The relative contribution of paracine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair. PLoS ONE 2013, 8.
194. Ye L., Chang Y.-H., Xiong Q., Zhang P., Zhang L., Somasundaram P., et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 2014, 15:750-761.
195. Ye Q., Zünd G., Benedikt P., Jockenhoevel S., Hoerstrup S.P., Sakyama S., et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiothorac. Surg. 2000, 17:587-591.
196. Yoon S.J., Fang Y.H., Lim C.H., Kim B.S., Son H.S., Park Y., et al. Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 91:163-171.
197. You J.-O., Rafat M., Ye G.J., Auguste D.T. Nanoengineering the heart: conductive scaffolds enhance connexin 43 expression. Nano Lett. 2011, 11:3643-3648.
198. Yu J., Gu Y., Du K.T., Mihardja S., Sievers R.E., Lee R.J. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials 2009, 30:751-756.
199. Zern M.A., Reid L.M. Extracellular Matrix: Chemistry: Biology, and Pathobiology With Emphasis on the Liver 1993, CRC Press.
200. Zhang H., Song P., Tang Y., Zhang X.-l., Zhao S.-h., Wei Y.-j., et al. Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. J. Thorac. Cardiovasc. Surg. 2007, 134:1234-1240. (e1).
201. Zhang P., Zhang H., Wang H., Wei Y., Hu S. Artificial matrix helps neonatal cardiomyocytes restore injured myocardium in rats. Artif. Organs 2006, 30:86-93.
202. Zieris A., Chwalek K., Prokoph S., Levental K., Welzel P., Freudenberg U., et al. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels. J. Control. Release 2011, 156:28-36.
203. Zieris A., Prokoph S., Levental K.R., Welzel P.B., Grimmer M., Freudenberg U., et al. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials 2010, 31:7985-7994.
204. Zimmermann W.-H., Didié M., Döker S., Melnychenko I., Naito H., Rogge C., et al. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc. Res. 2006, 71:419-429.
205. Zimmermann W.-H., Schneiderbanger K., Schubert P., Didie M., Münzel F., Heubach J., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 2002, 90:223-230.
206. Zwi L., Caspi O., Arbel G., Huber I., Gepstein A., Park I.-H., et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009, 120:1513-1523.